You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

16 Items
Cancer Type: Hematologic, Lymphoma - Hodgkin     
Intent: Curative
Nov 2017
Cancer Type: Breast     
Intent: Palliative
Funding:
ODB Limited Use
    anastrozole - For the treatment of metastatic breast cancer in hormone receptor positive post-menopausal women
Exceptional Access Program
    For the treatment of breast cancer according to clinical criteria
Updated
Sep 2019
Cancer Type: Hematologic, Lymphoma - Hodgkin     
Intent: Curative
Funding:
ODB - General Benefit
    procarbazine
ODB - General Benefit
    prednisone
Jun 2019
Cancer Type: Genitourinary, Testis     
Intent: Adjuvant, Curative
May 2019
Cancer Type: Genitourinary, Testis     
Intent: Adjuvant, Curative
May 2019
Cancer Type: Gynecologic, Germ Cell     
Intent: Adjuvant
May 2019
Cancer Type: Gynecologic, Germ Cell     
Intent: Curative
May 2019
Cancer Type: Genitourinary, Testis     
Intent: Curative
May 2019
Cancer Type: Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade     
Intent: Curative, Palliative
Funding:
ODB - General Benefit
    etoposide - oral capsules
ODB - General Benefit
    procarbazine
ODB - General Benefit
    prednisone
May 2019
Cancer Type: Hematologic, Leukemia - Acute Myeloid (AML)     
Intent: Palliative
Drugs Used:
enasidenib (Unfunded)
May 2019
Cancer Type: Breast     
Intent: Palliative
Funding:
Exceptional Access Program
    For the treatment of breast cancer according to clinical criteria
Drugs Used:
exemestane (Unfunded),
Updated
Sep 2019
Cancer Type: Breast     
Intent: Palliative
Drugs Used:
ribociclib (Unfunded),
fulvestrant (Unfunded)
Jun 2019